Back
Marcus Corp. 10K Form
Sell
44
MCS
Marcus Corp.
Last Price:
$17.37
Seasonality Move:
1.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | MCS/Marcus Corp. Quarterly |
| 2023-11-02 | 10Q | MCS/Marcus Corp. Quarterly |
| 2023-08-03 | 10Q | MCS/Marcus Corp. Quarterly |
| 2023-05-04 | 10Q | MCS/Marcus Corp. Quarterly |
| 2022-11-03 | 10Q | MCS/Marcus Corp. Quarterly |
| 2022-08-05 | 10Q | MCS/Marcus Corp. Quarterly |
Receive MCS News And Ratings
See the #1 stock for the next 7 days that we like better than MCS
MCS Financial Statistics
Sales & Book Value
| Annual Sales: | $758.5M |
|---|---|
| Cash Flow: | $26.4M |
| Price / Cash Flow: | 548.1 |
| Annual Sales: | $15.28 |
| Price / Book: | 1.17 |
Profitability
| EPS (TTM): | 0.39750 |
|---|---|
| Net Income (TTM): | $12.7M |
| Gross Margin: | $207M |
| Return on Equity: | 2.8% |
| Return on Assets: | 1.25% |
Marcus Corp. Earnings Forecast
Key Marcus Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for MCS is 27.29%.
-
The Selling, General & Administrative Expenses for MCS have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 90.39% of Operating Income.
-
The Net Earning history of MCS is 1.67% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 16 years.
Marcus Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Entertainment |
| Sector: | Communication Services |
| Current Symbol: | MCS |
| CUSIP: | 566330 |
| Website: | marcuscorp.com |
Debt
| Debt-to-Equity Ratio: | 0.73 |
|---|---|
| Current Ratio: | 0.4 |
| Quick Ratio: | 0.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 43.11 |
|---|---|
| Forward P/E Ratio: | 24.71 |
MCS Technical Analysis vs Fundamental Analysis
Sell
44
Marcus Corp. (MCS)
is a Sell
Is Marcus Corp. a Buy or a Sell?
-
Marcus Corp. stock is rated a SellThe current Marcus Corp. [MCS] share price is $17.49. The Score for MCS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.